MENU
MRKR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Marker Therapeutics (MRKR) Ownership - Who owns Marker Therapeutics?
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications... Show more
Industry: #Other Consumer Services
Profile
Industry
Other Consumer Services
Address
9350 Kirby Drive
Phone
+1 713 400-6400
Employees
8
Web
http//www.markertherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.78M
P/E Ratio
N/A
Total Cash
9M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MRKR
Capitalization
11.8M
P/E Ratio
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash
9M
Total Cash/Share
0.84
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.45M
P/B Ratio
1.58
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.92K
Current Ratio
3.15
Current Revenue Per Employee
52238.81
Dividends Per Share - Security
N/A
EBITDA
-10.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.01
Revenue To Assets
-63.80
Shares Held By Institutions
50M
Shares Outstanding - Current
10.7M
Total Liabilities
3.46M
Total Volume MTD
N/A
Value
1
Gain YTD
-64.630
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of cell based immune therapeutics and vaccines for cancer treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Other Consumer Services
Address
9350 Kirby Drive
Phone
+1 713 400-6400
Employees
8
Web
http//www.markertherapeutics.com